Crohn's disease (CD), characterized by idiopathic transmural inflammation anywhere along the gastrointestinal (GI) tract, is increasing in incidence worldwide for unknown reasons. The transmural inflammation can result in inflammatory, stricturing, or penetrating (fistulizing) phenotypes, all of which are notoriously difficult to treat. When a patient has inflammatory disease, medical immunosuppressive therapy with corticosteorids, immunomodulators, or biologics may be helpful before a fibrostenotic disease process starts. Once there is fibrosis, bowel damage is difficult to reverse, and proximal fistulizing disease may develop. Fistulizing disease, one of the most notoriously difficult disease manifestations can also occur anywhere along the GI tract, affecting portions as proximal as the duodenum or as distal as the anus with perianal and rectovaginal fistulas (RVFs).

Fistulizing Crohn's disease / Amy L., Lightner; Jean H., Ashburn; Mantaj S., Brar; Michele Carvello, F; Pramodh, Chandrasinghe; Anthony de Buck van, Overstraeten; Phillip R., Fleshner; Gallo, G; Paulo Gustavo, Kotze; Stefan D., Holubar; Lillian M., Reza; Antonino, Spinelli; Scott A., Strong; Philip J., Tozer; Adam, Truong; Janindra, Warusavitarne; Takayuki, Yamamoto; Karen, Zaghiyan. - In: CURRENT PROBLEMS IN SURGERY. - ISSN 0011-3840. - 57:11(2020). [10.1016/j.cpsurg.2020.100808]

Fistulizing Crohn's disease

Gallo G;
2020

Abstract

Crohn's disease (CD), characterized by idiopathic transmural inflammation anywhere along the gastrointestinal (GI) tract, is increasing in incidence worldwide for unknown reasons. The transmural inflammation can result in inflammatory, stricturing, or penetrating (fistulizing) phenotypes, all of which are notoriously difficult to treat. When a patient has inflammatory disease, medical immunosuppressive therapy with corticosteorids, immunomodulators, or biologics may be helpful before a fibrostenotic disease process starts. Once there is fibrosis, bowel damage is difficult to reverse, and proximal fistulizing disease may develop. Fistulizing disease, one of the most notoriously difficult disease manifestations can also occur anywhere along the GI tract, affecting portions as proximal as the duodenum or as distal as the anus with perianal and rectovaginal fistulas (RVFs).
2020
Crohn's disease; fistulizing; perianal fistulas; rectovaginal fistulas
01 Pubblicazione su rivista::01a Articolo in rivista
Fistulizing Crohn's disease / Amy L., Lightner; Jean H., Ashburn; Mantaj S., Brar; Michele Carvello, F; Pramodh, Chandrasinghe; Anthony de Buck van, Overstraeten; Phillip R., Fleshner; Gallo, G; Paulo Gustavo, Kotze; Stefan D., Holubar; Lillian M., Reza; Antonino, Spinelli; Scott A., Strong; Philip J., Tozer; Adam, Truong; Janindra, Warusavitarne; Takayuki, Yamamoto; Karen, Zaghiyan. - In: CURRENT PROBLEMS IN SURGERY. - ISSN 0011-3840. - 57:11(2020). [10.1016/j.cpsurg.2020.100808]
File allegati a questo prodotto
File Dimensione Formato  
Lightner_Fistulizing-Crohn’s-disease_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.08 MB
Formato Adobe PDF
3.08 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1661810
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 16
social impact